Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress

Featuring perspectives from Dr Alexandra Drakaki, Ms Krisztina Emodi, Dr Terence Friedlander and Ms Margarita Huober, moderated by Dr Friedlander, including the following topics: * Introduction: Basic Biology of Nonmetastatic Urothelial Bladder Cancer (UBC) (0:00) * Systemic Therapy for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer (MIBC) (13:35) * Evolving Approach to Systemic Therapy for Cisplatin-Ineligible Patients with MIBC (37:13) * Immune Checkpoint Inhibitors in Non-Muscle-Invasive Bladder Cancer (58:55) * Novel Intravesical Therapies for Nonmetastatic UBC (1:10:20) NCPD information and select publications [https://researchtopractice.com/ONS2026/nmBladder/Video]

Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress

Featuring perspectives from Dr Dana M Chase, Ms Sarah Karpen, Dr J Alejandro Rauh-Hain and Ms Jaclyn Shaver, moderated by Dr Chase, including the following topics: * Introduction: Biology of Endometrial Cancer (EC) (0:00) * First-Line Therapy for Advanced or Recurrent EC (14:15) * Potential Benefits of PARP Inhibition Combined with Immunotherapy in Advanced EC (35:13) * Role of Lenvatinib/Pembrolizumab in the Management of Progressive Advanced EC (57:48) * Other Nursing Considerations in the Care of Patients with Advanced EC (1:17:28) NCPD information and select publications [https://researchtopractice.com/ONS2026/Endometrial/Video]

Nonmelanoma Skin Cancers — An Interview with Dr Nikhil Khushalani

Dr Nikhil I Khushalani from the Moffitt Cancer Center in Tampa, Florida, discusses available and novel treatment strategies for nonmelanoma skin cancers. NCPD information and select publications here [https://www.researchtopractice.com/ONU2026/NonmelanomaSkin/Video].

Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis - Oncology Today with Dr Neil Love

Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Colorado, discusses circulating tumor DNA-based molecular residual disease assessment and its current role in the management of colorectal cancer. NCPD information and select publications here [https://www.researchtopractice.com/ONU2025/MRDCRC].

Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis

Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Colorado, discusses circulating tumor DNA-based molecular residual disease assessment and its current role in the management of colorectal cancer. NCPD information and select publications here [https://www.researchtopractice.com/ONU2025/MRDCRC].